Pharmacology

Resource Center

News
Research Summaries
Resources
From the Journal
Insights
Podcasts Q&As Videos
Interactive
Quizzes
Events & Education
ASHP Midyear

Research Summaries

FDA Alert
Child holding stomach
FDA Alert
First Treatment for Pediatric Functional Constipation Approved by FDA
06/15/2023
Jessica Ganga
The FDA approved the first treatment for pediatric patients who experience functional constipation
06/15/2023
COVID-19 Roundup
CR
COVID-19 Roundup
Combination Treatment Effective in Managing COVID-19, Incident Diabetes Associated With Infection, and More
06/09/2023
This COVID-19 roundup includes coverage of the combination of amubarvimab and romlusevimab to manage COVID-19 infection, the association between COVID-19 and incident diabetes, and the effectiveness of...
06/09/2023
FDA Alert
fda alert
FDA Alert
First Oral Treatment to Prevent Recurring Clostridioides difficile Infection Approved
06/01/2023
Jessica Ganga
The FDA has approved the first orally administered treatment for the gut infection—clostridioides difficile.
06/01/2023
FDA Alert
fda
FDA Alert
FDA Approves First Prescription Nasal Spray to Reverse Opioid Overdose
05/27/2023
Jessica Ganga
The FDA’s approval of nalmefene hydrochloride nasal spray marks the first of its kind for health care and community use.
05/27/2023
FDA alert
fda
FDA alert
First Oral Treatment Approved to Treat Moderate, Severe Crohn Disease
05/25/2023
Jessica Ganga
After clinical trials to assess the safety, efficacy, and maintenance use, the FDA has approved the first oral treatment for moderately to severely active Crohn disease.
05/25/2023
Research Summary
Research Summary
Treatment of Psoriatic Arthritis in Pregnant Women Increases Risks
04/28/2023
Jessica Ganga
The researchers evaluated the impact of antirheumatic treatment in women who are pregnant with psoriatic arthritis and how such treatment affects pregnancy outcomes.
04/28/2023
Conference Coverage
cc
Conference Coverage
Low-Dose Gemcitabine Beneficial Treatment for Platinum-Resistant Ovarian Cancer
04/21/2023
Jessica Ganga
Researchers evaluated the response rate of gemcitabine in patients with platinum-resistant ovarian cancer given at a low dosage. Their research was presented at the Hematology/Oncology Pharmacy...
04/21/2023
FDA ALERT
medication
FDA ALERT
FDA Approves First Treatment for Rare, Degenerative Disease
04/18/2023
Jessica Ganga
The FDA has approved a treatment for Friedreich ataxia after the results of randomized, placebo-controlled study indicate a strong effectiveness in treatment.
04/18/2023
Conference Coverage
cc
Conference Coverage
HIV Persistence Reduced After Doubling Antiretroviral Therapy in Patients
04/18/2023
Researchers evaluated the impact an intensified dose of dolutegravir had on patients living with HIV. Their research was presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2023...
04/18/2023
Research Summary
Research Summary
Most Adults With Diabetes Can Use GLP-1 RAs, SGLT-2 Inhibitors But Don't
04/17/2023
Researchers set out to determine the percentage of people in the United States with type 2 diabetes who meet the recommended criteria to use GLP-1 receptor agonists and SGLT-2 inhibitors as well as patients...
04/17/2023